Clinical Trial

Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain. Salt sensitivity of BP will be assessed using 7-day dietary feeding where participants will be given food to consume for 7-days. Comparisons will be made between salt resistant (no change in blood pressure going from low to high salt diets) and salt sensitive adults (a change in blood pressure going from low to high salt diets). The investigators think the changes in MRI will be greater in salt sensitive compared to salt resistant subjects.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-17; most recent amendment 2026-03-20.
Status change: Not Yet Recruiting → Recruiting 2024-03-13
Trial Details
NCT Number NCT06094816
Lead Sponsor University of Delaware
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Salt-Sensitivity of Blood Pressure
Enrollment 120 participants
Start Date 2024-03-05
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-24